According to Dr. Patricia K. Coyle, the nature of unmanaged multiple sclerosis (MS) produces recurrent attacks on the brain and spinal cord, which results in focal inflammatory lesions that can be visualized with magnetic resonance imaging (MRI). Unfortunately, 80-90% of lesions that form are silent and cannot be detected on the neurological examination, which exposes patients to a greater burden of disease and an increased risk of dysfunction. Furthermore, depending on which neurological components are affected, patients are at heightened risk for a broad suite of deficits, including weakness, spasticity, sensory loss, and cognitive issues. As the disease progresses, symptomatology may include bladder disruption, walking abnormalities, tremor, and fatigue.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More